Milne Calls On Leahy To Answer Basic Questions Related To EB-5 Scandal
U.S. Senate Candidate Scott Milne today asked Senator Leahy to answer questions in light of the developing web of impropriety surrounding the EB-5 scandal.
At a press conference in South Burlington, Milne said “it appears our Senator participated in an intimate event with Mr. Leamy and other EB-5 interests in early May of 2014… The timing of all this is of great consequence because this apparent event and these EB-5 contributions happened just a week after the Securities and Exchange Commission began questioning Mr. Leamy’s boss, Ariel Quiros. Within a couple of weeks, both Bill Stenger and Quiros would be deposed by the SEC. These revelations come after we learn that Senator Leahy’s daughter was hired to lobby Congress on behalf of Hollywood, which is a strong supporter of EB-5. Hollywood has donated hundreds of thousands of dollars to curry favor with Leahy in just this election cycle. And, Pat Leahy supports a number of their key priorities, including having guided EB-5’s reauthorization in 2012.
“This whole affair has more loose ends than a bowl of spaghetti, and Senator Leahy alone can bring clarity by doing nothing more than what he has for decades demanded of others: open up your records to public scrutiny and answer legitimate questions. I ask Pat Leahy:
Why, despite portraying yourself as an advocate for transparency, including increased transparency for Congress, will you not voluntarily provide the EB-5 records, and the other records that have been repeatedly requested?
Where did your fundraising events in early May of 2014 take place, and who was in attendance?
When questioned by VTDigger about the Charles Leamy contribution, you said, and I quote: ‘I wouldn’t be surprised if this had to do with an immigration issue,’ because you were working on EB-5 legislation at the time. Would this not be surprising to you because it is your practice to collect campaign contributions in connection with legislation you are actively pushing? Why else would you associate a campaign contribution with a legislative initiative?
When did you first obtain information that the investments in the Jay, Burke, and Newport projects may not be sound?
Why did you discredit the Department of Homeland Security Inspector General’s investigation into Alejandro Mayorkas’s management of EB-5 projects in Southern California?
Given your pledge to return Jay Peak related contributions, why will you not also return contributions from other corporate wrongdoers such as Mylan and Wells Fargo? This lack of consistency leads people to believe you are returning Jay Peak contributions simply to shut down questioning about the EB-5 scandal.”
- Vermont EB5 Regional Center
- Jay Peak - Q Burke Mountain Resort, Hotel and Conference Center L.P.
- UNITED STATES SECURITIES AND EXCHANGE COMMISSION
- Ariel Quiros
- Bill Stenger
- Patrick Leahy
- State of Vermont vs Bill Stenger & Ariel Quiros
- UNITED STATES SECURITIES AND EXCHANGE COMMISSION vs Ariel Quiros & Bill Stenger
Subscribe for News
Join Professionals on EB5Projects.com →
This website is for informational purposes only and does not constitute an offer or solicitation to sell shares or securities. Any such offer or solicitation will be made only by means of an investment's confidential Offering Memorandum and in accordance with the terms of all applicable securities and other laws. This website does not constitute or form part of, and should not be construed as, any offer for sale or subscription of, or any invitation to offer to buy or subscribe for, any securities, nor should it or any part of it form the basis of, or be relied on in any connection with, any contract or commitment whatsoever. EB5Projects.com LLC and its affiliates expressly disclaim any and all responsibility for any direct or consequential loss or damage of any kind whatsoever arising directly or indirectly from: (i) reliance on any information contained in the website, (ii) any error, omission or inaccuracy in any such information or (iii) any action resulting therefrom.